Porocarcinoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Porocarcinoma | |
|---|---|
| |
| Synonyms | Malignant eccrine poroma, eccrine porocarcinoma |
| Pronounce | N/A |
| Specialty | Dermatology, Oncology |
| Symptoms | Skin lesion, ulceration, bleeding |
| Complications | N/A |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutations, UV radiation |
| Risks | Sun exposure, immunosuppression |
| Diagnosis | Biopsy, histopathology |
| Differential diagnosis | Squamous cell carcinoma, basal cell carcinoma, melanoma |
| Prevention | N/A |
| Treatment | Surgical excision, radiation therapy, chemotherapy |
| Medication | N/A |
| Prognosis | Variable, depends on stage and treatment |
| Frequency | Rare |
| Deaths | N/A |
Porocarcinoma, also known as eccrine porocarcinoma, is a rare type of skin cancer that originates from the eccrine sweat glands. It is considered a malignant form of poroma, a benign sweat gland tumor. Porocarcinoma is most commonly found in the elderly population and can occur anywhere on the body, although it frequently appears on the lower extremities.
Clinical Presentation[edit]
Porocarcinoma typically presents as a solitary, slow-growing nodule or plaque that may be ulcerated or bleeding. The lesion can vary in color, appearing as red, pink, or brown. Due to its nonspecific appearance, porocarcinoma can be mistaken for other skin conditions such as basal cell carcinoma, squamous cell carcinoma, or melanoma.
Pathophysiology[edit]
Porocarcinoma arises from the intraepidermal portion of the eccrine sweat glands. The exact cause of porocarcinoma is not well understood, but it is believed to be associated with genetic mutations and ultraviolet radiation exposure. The tumor cells exhibit atypical features and can invade surrounding tissues, leading to potential metastasis.
Diagnosis[edit]
The diagnosis of porocarcinoma is confirmed through a biopsy and histopathological examination. Under the microscope, porocarcinoma is characterized by atypical cells with ductal differentiation. The presence of ductal structures and infiltrative growth patterns are key features in distinguishing porocarcinoma from other skin malignancies.
Treatment[edit]
The primary treatment for porocarcinoma is surgical excision with clear margins. Mohs micrographic surgery is often employed to ensure complete removal of the tumor while preserving healthy tissue. In cases where the tumor has metastasized, additional treatments such as radiation therapy or chemotherapy may be considered.
Prognosis[edit]
The prognosis for porocarcinoma depends on the stage at diagnosis and the presence of metastasis. Early detection and complete surgical removal generally result in a favorable outcome. However, advanced cases with regional or distant metastasis have a poorer prognosis.
See Also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
